➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Baxter
Johnson and Johnson
Moodys
McKinsey

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Vaniprevir


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Vaniprevir?

Vaniprevir is an investigational drug.

There have been 11 clinical trials for Vaniprevir. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2011.

The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, and Hepatitis A. The leading clinical trial sponsors are Merck Sharp & Dohme Corp. and [disabled in preview].

Recent Clinical Trials for Vaniprevir
TitleSponsorPhase
Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)Merck Sharp & Dohme Corp.Phase 1
Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)Merck Sharp & Dohme Corp.Phase 3
Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)Merck Sharp & Dohme Corp.Phase 3

See all Vaniprevir clinical trials

Clinical Trial Summary for Vaniprevir

Top disease conditions for Vaniprevir
Top clinical trial sponsors for Vaniprevir

See all Vaniprevir clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Merck
Medtronic
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.